170 related articles for article (PubMed ID: 361576)
21. Influence of sialic contents on the chemiluminescent response of human leucocytes to group B streptococci.
De Paoli P; Mucignat C; Orefici G; Santini G
Microbiologica; 1985 Oct; 8(4):379-86. PubMed ID: 3906368
[TBL] [Abstract][Full Text] [Related]
22. Hyaluronidase activity of group B streptococci.
Benchetrit LC; Avelino CC; Oliveira CM
Braz J Med Biol Res; 1987; 20(3-4):411-4. PubMed ID: 3330462
[TBL] [Abstract][Full Text] [Related]
23. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci.
Marques MB; Kasper DL; Pangburn MK; Wessels MR
Infect Immun; 1992 Oct; 60(10):3986-93. PubMed ID: 1398910
[TBL] [Abstract][Full Text] [Related]
24. Neuraminidase production by streptococci from patients with glomerulonephritis.
Mosquera JA; Katiyar VN; Coello J; Rodríguez-Iturbe B
J Infect Dis; 1985 Feb; 151(2):259-63. PubMed ID: 2578533
[TBL] [Abstract][Full Text] [Related]
25. Streptococcus group B isolates in a regional hospital area.
Nitzan Y; Maayan M; Wajsman C
Med Microbiol Immunol; 1980; 169(1):21-30. PubMed ID: 7007849
[TBL] [Abstract][Full Text] [Related]
26. [Investigation of the serotype distribution, biofilm production and antibiotic susceptibilities of group B streptococci isolated from urinary samples].
Baba S; Aydın MD
Mikrobiyol Bul; 2016 Jul; 50(3):353-60. PubMed ID: 27525391
[TBL] [Abstract][Full Text] [Related]
27. Serotypes of group B streptococci and their relation to hyaluronidase production and hydrolysis of salicin.
Kjems E; Perch B; Henrichsen J
J Clin Microbiol; 1980 Feb; 11(2):111-3. PubMed ID: 6987261
[TBL] [Abstract][Full Text] [Related]
28. Growth of group B streptococci in human serum leads to increased cell surface sialic acid and decreased activation of the alternative complement pathway.
Platt MW; Correa N; Mold C
Can J Microbiol; 1994 Feb; 40(2):99-105. PubMed ID: 8019940
[TBL] [Abstract][Full Text] [Related]
29. Growth and amino acid requirements of various strains of group B streptococci.
Milligan TW; Doran TI; Straus DC; Mattingly SJ
J Clin Microbiol; 1978 Jan; 7(1):28-33. PubMed ID: 342537
[TBL] [Abstract][Full Text] [Related]
30. Density profile of group B streptococci, type III, and its possible relation to enhanced virulence.
Håkansson S; Holm SE; Wagner M
J Clin Microbiol; 1987 Apr; 25(4):714-8. PubMed ID: 3106411
[TBL] [Abstract][Full Text] [Related]
31. Phylogenetic lineages of invasive and colonizing strains of serotype III group B Streptococci from neonates: a multicenter prospective study.
Lin FY; Whiting A; Adderson E; Takahashi S; Dunn DM; Weiss R; Azimi PH; Philips JB; Weisman LE; Regan J; Clark P; Rhoads GG; Frasch CE; Troendle J; Moyer P; Bohnsack JF
J Clin Microbiol; 2006 Apr; 44(4):1257-61. PubMed ID: 16597848
[TBL] [Abstract][Full Text] [Related]
32. Penicillin tolerance in group B streptococci isolated from infected neonates.
Kim KS; Anthony BF
J Infect Dis; 1981 Nov; 144(5):411-9. PubMed ID: 7031141
[TBL] [Abstract][Full Text] [Related]
33. Properties of extracellular neuraminidase produced by group A streptococcus.
Davis L; Baig MM; Ayoub EM
Infect Immun; 1979 Jun; 24(3):780-6. PubMed ID: 38208
[TBL] [Abstract][Full Text] [Related]
34. Nosocomial transmission of bacteriophage type 7/11/12 group B streptococci in a special care nursery.
Boyer KM; Vogel LC; Gotoff SP; Gadzala CA; Stringer J; Maxted WR
Am J Dis Child; 1980 Oct; 134(10):964-6. PubMed ID: 6999891
[TBL] [Abstract][Full Text] [Related]
35. Serotype, virulence profile, antimicrobial resistance and macrolide-resistance determinants in Streptococcus agalactiae isolates in pregnant women and neonates in Catalonia, Spain.
López Y; Parra E; Cepas V; Sanfeliú I; Juncosa T; Andreu A; Xercavins M; Pérez J; Sanz S; Vergara A; Bosch J; Soto SM
Enferm Infecc Microbiol Clin (Engl Ed); 2018 Oct; 36(8):472-477. PubMed ID: 29029763
[TBL] [Abstract][Full Text] [Related]
36. Characterization of Streptococcus agalactiae strains by multilocus enzyme genotype and serotype: identification of multiple virulent clone families that cause invasive neonatal disease.
Quentin R; Huet H; Wang FS; Geslin P; Goudeau A; Selander RK
J Clin Microbiol; 1995 Oct; 33(10):2576-81. PubMed ID: 8567885
[TBL] [Abstract][Full Text] [Related]
37. Role of cellular lipoteichoic acids in mediating adherence of serotype III strains of group B streptococci to human embryonic, fetal, and adult epithelial cells.
Nealon TJ; Mattingly SJ
Infect Immun; 1984 Feb; 43(2):523-30. PubMed ID: 6363289
[TBL] [Abstract][Full Text] [Related]
38. [Group B streptococci: serotyping data and susceptibility to antibiotics (author's transl)].
Rousset A; Lévy A; Minck R
Ann Microbiol (Paris); 1977 Oct; 128(3):339-48. PubMed ID: 341773
[TBL] [Abstract][Full Text] [Related]
39. Identification of the high-virulence clone of group B streptococci in Mexican isolates by growth characteristics at 40 degrees C.
Palacios GC; Eskew EK; Solorzano F; Mattingly SJ
Curr Microbiol; 1999 Feb; 38(2):126-31. PubMed ID: 9871112
[TBL] [Abstract][Full Text] [Related]
40. Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R.
Hordnes K; Tynning T; Kvam AI; Bevanger L; Brown TA; Jonsson R; Haneberg B
Scand J Immunol; 1998 Feb; 47(2):179-88. PubMed ID: 9496695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
